See also this year's filing and all EDGAR filings for this company.
PDF Report 0001424812_2016_Amarantus_Bioscience_Holdings_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001424812, Amarantus Bioscience Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 828,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 10,828,000 |
| 2 | PropertyPlantAndEquipmentNet | 115,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 16,192,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,113,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,565,000 |
| 9 | ResearchAndDevelopmentExpense | 13,256,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -393,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,771,000 |
| 1 | Liabilities | 17,305,000 |
| 2 | Expenses | 24,821,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -5,534,000 |
| 5 | NetIncome | -25,214,000 |
| 6 | ComprehensiveNetIncome | -25,214,000 |
| 7 | BaseVar | 27,145,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.56 |
| 9 | EconomicCapitalRatio | 0.834 |
Edgar->Model Mapping
Feature Distribution
Change over Time
